Versant Venture Capital VI, L.P.
Related Filers (34)
- Versant Ventures VI GP, L.P. (40)
- Versant Ventures VI GP-GP, LLC (40)
- Versant Vantage I, L.P. (39)
- Black Diamond Therapeutics, Inc. (28)
- Versant Voyageurs I Parallel, L.P. (22)
- Versant Voyageurs I, L.P. (22)
- Oyster Point Pharma, Inc. (16)
- Akero Therapeutics, Inc. (15)
- Versant Vantage I GP, L.P. (15)
- Versant Vantage I GP-GP, LLC (15)
- Versant Venture Capital IV, L.P. (11)
- Versant Ventures IV, LLC (11)
- Versant Side Fund IV, L.P. (11)
- Versant Ventures V, LLC (10)
- Versant Ophthalmic Affiliates I, L.P. (10)
- Versant Ventures V (Canada), L.P. (10)
- Repare Therapeutics Inc. (10)
- Versant Venture Capital V, L.P. (10)
- Versant Affiliates Fund V, L.P. (10)
- Versant Venture Capital V (Canada), LP (10)
- Versant Ventures V GP-GP (Canada), Inc. (10)
- Versant Vantage II GP-GP, LLC (8)
- Versant Vantage II GP, L.P. (8)
- Versant Vantage II, L.P. (8)
- Century Therapeutics, Inc. (7)
- Aligos Therapeutics, Inc. (5)
- Tempest Therapeutics, Inc. (5)
- Passage BIO, Inc. (4)
- Monte Rosa Therapeutics, Inc. (4)
- Graphite Bio, Inc. (4)
- Pandion Therapeutics, Inc. (3)
- Woiwode Thomas (2)
- Versant Venture Capital VI (Canada) LP (1)
- LAVA Therapeutics NV (1)
- Show More ...
Other (2)
D/A
Tuesday, 1/3/2017
Exempt (Private) Offering
D
Thursday, 11/3/2016
Exempt (Private) Offering
Ownership (102)
SC 13D/A
Friday, 11/17/2023
Graphite Bio, Inc.: Major Shareholders
SC 13D/A
Thursday, 11/9/2023
Black Diamond Therapeutics, Inc.: Major Shareholders
SC 13D/A
Thursday, 11/9/2023
Passage BIO, Inc.: Major Shareholders
SC 13D/A
Thursday, 11/9/2023
Monte Rosa Therapeutics, Inc.: Major Shareholders
SC 13D/A
Thursday, 11/9/2023
Tempest Therapeutics, Inc.: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
Century Therapeutics, Inc.: Major Shareholders
SC 13D/A
Friday, 1/13/2023
Oyster Point Pharma, Inc.: Major Shareholders
4
Wednesday, 1/4/2023
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/11/2022
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/7/2022
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 5/9/2022
Tempest Therapeutics, Inc.: Major Shareholders
4
Tuesday, 5/3/2022
Tempest Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/11/2022
Tempest Therapeutics, Inc.: Major Shareholders
SC 13G
Friday, 2/11/2022
Century Therapeutics, Inc.: Major Shareholders
4
Wednesday, 2/2/2022
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 1/13/2022
Oyster Point Pharma, Inc.: Major Shareholders
4
Friday, 1/7/2022
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/28/2021
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 10/27/2021
Oyster Point Pharma, Inc.: Major Shareholders
4
Wednesday, 10/20/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/9/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 7/9/2021
Graphite Bio, Inc.: Major Shareholders
SC 13D
Thursday, 7/8/2021
Monte Rosa Therapeutics, Inc.: Major Shareholders
3
Tuesday, 7/6/2021
Tempest Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/1/2021
Graphite Bio, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/24/2021
Graphite Bio, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/23/2021
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/23/2021
Monte Rosa Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 6/21/2021
Aligos Therapeutics, Inc.: Major Shareholders
3
Thursday, 6/17/2021
Century Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/3/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 5/24/2021
Oyster Point Pharma, Inc.: Major Shareholders
4
Friday, 5/14/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/7/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 5/3/2021
Aligos Therapeutics, Inc.: Major Shareholders
SC 13D
Thursday, 4/8/2021
LAVA Therapeutics NV: Major Shareholders
SC 13D/A
Monday, 4/5/2021
Oyster Point Pharma, Inc.: Major Shareholders
4
Tuesday, 3/30/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 3/1/2021
Oyster Point Pharma, Inc.: Major Shareholders
4
Friday, 2/19/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/16/2021
Akero Therapeutics, Inc.: Major Shareholders
4
Tuesday, 2/2/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/19/2021
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/17/2020
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/16/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 12/3/2020
Black Diamond Therapeutics, Inc.: Major Shareholders
4
Tuesday, 12/1/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/25/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 11/23/2020
Black Diamond Therapeutics, Inc.: Major Shareholders
4
Monday, 11/23/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/19/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/17/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/12/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/10/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/6/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 10/30/2020
Aligos Therapeutics, Inc.: Major Shareholders
4
Wednesday, 10/28/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/20/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/20/2020
Aligos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/15/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/15/2020
Aligos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 10/13/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/8/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 9/25/2020
Black Diamond Therapeutics, Inc.: Major Shareholders
4
Monday, 9/21/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 8/21/2020
Black Diamond Therapeutics, Inc.: Major Shareholders
4
Thursday, 8/20/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/14/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/12/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 7/31/2020
Pandion Therapeutics, Inc.: Major Shareholders
4
Wednesday, 7/29/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/21/2020
Pandion Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/16/2020
Pandion Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4/A
Friday, 7/10/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 7/10/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/25/2020
Repare Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/18/2020
Repare Therapeutics Inc.: Initial statement of beneficial ownership of securities
SC 13D
Friday, 3/13/2020
Passage BIO, Inc.: Major Shareholders
4
Tuesday, 3/3/2020
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/27/2020
Passage BIO, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Friday, 2/14/2020
Akero Therapeutics, Inc.: Major Shareholders
SC 13D
Thursday, 2/13/2020
Black Diamond Therapeutics, Inc.: Major Shareholders
4
Wednesday, 2/5/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/29/2020
Black Diamond Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 1/21/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/15/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/9/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/6/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/31/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 12/31/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/26/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/19/2019
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 11/14/2019
Oyster Point Pharma, Inc.: Major Shareholders
4
Monday, 11/4/2019
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/30/2019
Oyster Point Pharma, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 7/5/2019
Akero Therapeutics, Inc.: Major Shareholders